Xvivo Perfusion AB (publ) (0RKL.L) Stock Price

SEK319.7 0%

Sign up
to add to portfolio

AI Score

Buy

  • Alternative

    8

  • Fundamental

    8

  • Technical

    6

Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.

Sign up to get access to more historical data and insights on Xvivo Perfusion AB (publ), AI stock picks, stock alerts and much more.

Sign up

0RKL.L AI Stock Analysis

AI stock analysis for 0RKL.L is missing at the moment.

Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Xvivo Perfusion AB (publ) (0RKL.L) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.

Sign up and become a member to get access to AI stock analysis.

Sign up

Xvivo Perfusion AB (publ) (0RKL.L) Price Prediction

Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Xvivo Perfusion AB (publ) (0RKL.L), currently trading at SEK319.7, will... Sign up to access price prediction.

Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.

About 0RKL.L

LSE

  • Xvivo Perfusion AB (publ), a medical technology company, develops solutions for organ, tissue, and cell preservation and perfusion in connection with transplantation in Sweden, the United States, North America and South America, Europe, the Middle East, Africa, and the Asia Pacific.

  • Symbol

    0RKL.L

  • Market

    LSE

  • Industry

    Medical - Equipment & Services

  • Market Cap

    9.5B

Similar Stocks

0HRS.L CVS Health Corporation
0HRS.L		 $65.31
0.2%
5
0HVB.L Centene Corporation
0HVB.L		 $57.27
6.1%
7
0R2S.L Stryker Corporation
0R2S.L		 $365.1
1.5%
7
0JZU.L McKesson Corporation
0JZU.L		 $693.4
0.7%
6
0Y6X.L Medtronic
0Y6X.L		 $83.95
0.2%
7

News

No news articles.

0RKL.L Alternative Data

Web Traffic

Xvivo Perfusion AB (publ) receives an estimated 2046 monthly visitors to xvivoperfusion.com.

  • Web Traffic

    2046

  • Change from Previous Month

    615.4%

  • 3 Month Change

    424.6%

  • YoY Change

    424.6%

Twitter Followers

Xvivo Perfusion AB (publ) has 469 Twitter Followers on its main Twitter (also known as X) account, which is up by 0.9% over the last month.

  • Twitter Followers

    469

  • Daily Change

    0.2%

  • 1 Month Change

    0.9%

  • 3 Month Change

    3.5%

Job Postings

Xvivo Perfusion AB (publ) currenly has an estimated 2 open job postings.

  • Job Postings

    2

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    33.3%

News Mentions

Xvivo Perfusion AB (publ) was mentioned 0 times in the news yesterday.

  • News Mentions

    0

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    0%

Reddit Mentions

Xvivo Perfusion AB (publ) has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.

  • Reddit Mentions

    0

  • Daily Change

    0%

  • 1 Month Change

    0%

LinkedIn Followers

10,024 are following Xvivo Perfusion AB (publ) on LinkedIn, up by 2% over the last month.

  • LinkedIn Followers

    10024

  • Daily Change

    0.1%

  • 1 Month Change

    2%

  • 3 Month Change

    6.8%

LinkedIn Employees

According to LinkedIn, Xvivo Perfusion AB (publ) has 205 employees.

  • LinkedIn Employees

    205

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    5.1%

0RKL.L Financials

0RKL.L Key Metrics

  • Total Revenue

    SEK227.6M

  • Net Income

    SEK36.4M

  • Earnings per Share

    SEK1.16

  • Free cash flow

    SEK62.1M

  • EBITDA

    SEK15.5M

  • EBITDA Ratio

    0.0679457

  • Total Assets

    SEK2.4B

0RKL.L 2-year Revenue & Income
0RKL.L 2-year Free Cash Flow

0RKL.L Technicals

0RKL.L SMA
0RKL.L RSI

FAQ

What's the current price of Xvivo Perfusion AB (publ) (0RKL.L) Stock?
The price of an Xvivo Perfusion AB (publ) (0RKL.L) share is SEK319.7.

What's the market cap of Xvivo Perfusion AB (publ)?
The current market cap of Xvivo Perfusion AB (publ) is 9.5B.

Should I buy or sell 0RKL.L?
Multiple alternative data signals suggest that Xvivo Perfusion AB (publ) stock could offer a buying opportunity at its current level, with a reasonable expectation for positive performance in the mid term.

Is Xvivo Perfusion AB (publ) a good investment?
Based on an in-depth analysis that encompasses fundamentals, technical analysis, and alternative data insights, it appears to be a favorable time to consider investing in Xvivo Perfusion AB (publ) stock. The bullish indicators suggest that Xvivo Perfusion AB (publ)'s growth prospects and market position may lead to a positive performance in the foreseeable future.

Is now a good time to buy Xvivo Perfusion AB (publ) (0RKL.L) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, it could be a favorable time to consider buying Xvivo Perfusion AB (publ) stock, given the bullish outlook.

What are some stocks similar to Xvivo Perfusion AB (publ) (0RKL.L) that investors often compare it to?
Xvivo Perfusion AB (publ) (0RKL.L) is often compared to similar stocks such as CVS Health Corporation, Centene Corporation, Stryker Corporation, McKesson Corporation and Medtronic.

What is the forecast for Xvivo Perfusion AB (publ)'s stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Xvivo Perfusion AB (publ)'s stock price to be around SEK352.2 in 2026. Starting from the current price of SEK319.7, this represents a 10.2% change in price, indicating a bullish outlook for the stock.

How to buy Xvivo Perfusion AB (publ) (0RKL.L) Stock?
Xvivo Perfusion AB (publ) stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Xvivo Perfusion AB (publ) shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.